The prevalence of extended-spectrum beta-lactamases and CTX-M-1 producing escherichia coli in urine samples collected at Tabriz City Hospitals

Tehran University Medical Journal

Volumn 69, Issue 5, 2011, Pages 273-278

  Dallal, Mohammad Mehdi Soltan ^a   Azarsa, Mohammad ^a   Shirazi, Mohammad Hassan ^a   Lari, Abdolaziz Rastegar ^a   Owlia, Parviz ^b   Mehrabadi, Jalil Fallah ^c   Sabbaghi, Aylar ^a   Aghamirzaei, Hedrosha Molla ^a   Shamkani, Farnaz ^d   Yans, Sevan Avadis ^a   Mobasseri, Golnaz ^a   Bakhtiari, Ronak ^a   Yazdi, Mohammad Kazem Sharifi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c MARS Bioinformatics Institute   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial resistance; CTX M 1; Escherichia coli; Extended spectrum beta lactamase

Indexed keywords

BETA LACTAMASE CTX M; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BETA LACTAMASE CTX M GENE; CITY; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; IRAN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING TEST; URINALYSIS;

EID: 80052463447     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Escudero E, Vinué L, Teshager T, Torres C, Moreno MA. Resistance mechanisms and farm-level distribution of fecal Escherichia coli isolates resistant to extended-spectrum cephalosporins in pigs in Spain. Res Vet Sci 2010;88(1):83-7.
2. Falagas ME, Karageorgopoulos DE. Extended-spectrum betalactamase-producing organisms. J Hosp Infect 2009;73(4):345-54.
3. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000;14(2):137-42.
4. Azap OK, Arslan H, Serefhanoǧlu K, Colakoǧlu S, Erdoǧan H, Timurkaynak F, Senger SS. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 2010;16(2):147-51.
5. Fleming PC, Goldner M, Glass DG. Observations on the nature, distribution, and significance of cephalosporinase. Lancet 1963;1(7296):1399-401.
6. Raveh D, Yinnon AM, Broide E, Rudensky B. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy 2007;53(3):185-9.
7. Mirzaee M, Pourmand MR, Chitsaz M, Mansouri S. Antibiotic resistance to third generation cephalosporins dueto CTX-M-Type extended-spectrum β-lactamases in clinical isolates of Escherichia coli. Iranian J Publ Health 2009;38(1):10-7.
8. Yu X, Susa M, Weile J, Knabbe C, Schmid RD, Bachmann TT. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray. Int J Med Microbiol 2007;297(6):417-29.
9. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18(4):657-86.
10. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement, M100-17. Wayne: CLSI, 2007.
11. Soltan Dallal MM, Mobasseri G, Fallah Mehrabadi J, Eshraghian MR, Rastegar Lari A, Molla Aghamirzaei H, et al. Detection of CTX-M-1 beta lactamase gene in Escherichia coli isolated from clinical samples by Polymerase Chain Reaction (PCR). Tehran Uni Med J 2011;69(1):16-21.
12. Soltan Dallal MM, Molla Aghamirzaei H, Fallah Mehrabadi J, Sabbaghi A, Rastegar Lari A, Eshraghian MR, et al. Molecular detection of TEM and AmpC (Dha, mox) broad spectrum β-lactamase in clinical isolates of Escherichia coli: PCR method. Tehran Uni Med J 2010;68(6):872-7.
13. Yates C, Amyes S. Extended-spectrum beta-lactamases in nontyphoidal Salmonella spp. isolated in the UK are now a reality: why the late arrival? J Antimicrob Chemother 2005;56(2):262-4.
14. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59(2):165-74.
15. Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G, et al. CTX-M-type extended-spectrum betalactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006;50(8):2700-6.
16. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9(5):466-75.
17. Masjedian GF, Valehi F, Talebi, Rastegar Lari A. Moulecular evaluation of resistance to espanded antibiotics in Escherichia coli and Klebsiella pneumoniae. Iran J Med Microbiol 2007;1(2):27-34. [Persian]
18. Sadeghi MR, Nahaei MR, Soltan Dallal MM. Resistance to Extended Spectrum β-Lactam antibiotics in Escherichia coli and Klebsiella pneumoniae from hospital. Tabriz Uni Med J 2008;30(2):79-86. [Persian]
19. Mirsalehian A, Akbari-Nakhjavani F, Peymani A, Kazemi B, Jabal Ameli F, Mirafshar SM. Prevalence of Extended Spectrum β- Lactamase-Producing Enterobacteriaceae by phenotypic and genotypic methods in intensive care units in Tehran. Daru 2008;16(3):169-173.
20. Shahcheraghi F, Nasiri S and Naviri H. Evalouation of presence the bla-SHV and bla-TEM β-Lactamase genes in clinical isolates resistant Escherichia coli to antibiotics from Tehran hospital. Iran J Med Microbiol 2007;1(3):1-8. [Persian]
21. Soltan Dallal MM, Sabbaghi A, Fallah Mehrabadi J, Molla Aghamirzaei H, Rastegar Lari A, Eshraghian MR, Fard Saneei A. Evaluation of presence the bla-SHV and bla-AmpC (CITM, FOX) β-lactamase genes in clinical isolates of Escherichia coli. Iran J Med Council 2010;28(3):269-276.